Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 2Oligodendroglioma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Astrocytoma 1Advanced Breast Cancer 1

Interventions

Temozolomide 11Radiotherapy 10Cisplatin 4Carmustine 4Vincristine 3Surgical Procedures, Operative 3Methotrexate 3Lomustine 3Chlorotoxin 3Carboplatin 3Thiotepa 2Etoposide 2Cyclophosphamide 2Chemotherapy, Adjuvant 2Amplified Fragment Length Polymorphism Analysis 2lonafarnib 1interleukin-4-Pseudomonas exotoxin 1Verteporfin 1Valproic Acid 1Tranexamic Acid 1Tf-CRM107 1Tamoxifen 1Procarbazine 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Neoadjuvant Therapy 1Metformin 1Metabolism 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Astrocytoma × In Situ Hybridization, Fluorescence × Clear all
NCT00360945 2013-09-17

Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma

National Cancer Institute (NCI)

Phase 2 Unknown
87 enrolled
CNS

Astrocytoma, Oligodendroglioma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡